Medical oncologist Dr. Greg Riely, MSKCC, summarizes the development of acquired resistance after a good initial response to EGFR inhibitor therapy and the clinical patterns of progression commonly seen.
Patterns of Acquired Resistance to EGFR TKIs in EGFR Mutation-Positive NSCLC [720p]
